after earnings:
38.04 -1.77 (-4.45%)
After Hours: 33.00 -5.04 (-13.25%)
Jan 30, 4:22PM EST
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the third fiscal quarter ended December 31, 2013.
Quarterly highlights include:
Quarterly Results: For the fiscal quarter ended December 31, 2013, Abaxis reported revenues of $40.8 million, as compared with revenues of $49.8 million for the comparable period last year, a decrease of 18 percent. Revenues from sales of instruments, which include chemistry analyzers, hematology instruments, VSpro specialty analyzers and i-STAT analyzers, decreased by $5.8 million, or 42 percent, compared to the same period last year.
daily heikin
daily
weekly
No comments:
Post a Comment